- Home
- EDRY vs COCH Comparison
EDRY vs COCH Comparison
Compare EDRY & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- COCH
- Stock Information
- Founded
- EDRY 2018
- COCH 1995
- Country
- EDRY Greece
- COCH United States
- Employees
- EDRY N/A
- COCH N/A
- Industry
- EDRY Marine Transportation
- COCH Blank Checks
- Sector
- EDRY Consumer Discretionary
- COCH Finance
- Exchange
- EDRY Nasdaq
- COCH Nasdaq
- Market Cap
- EDRY 25.2M
- COCH 31.6M
- IPO Year
- EDRY N/A
- COCH N/A
- Fundamental
- Price
- EDRY $9.65
- COCH $1.44
- Analyst Decision
- EDRY
- COCH Strong Buy
- Analyst Count
- EDRY 0
- COCH 2
- Target Price
- EDRY N/A
- COCH $9.25
- AVG Volume (30 Days)
- EDRY 7.4K
- COCH 21.8K
- Earning Date
- EDRY 06-05-2025
- COCH 08-11-2025
- Dividend Yield
- EDRY N/A
- COCH N/A
- EPS Growth
- EDRY N/A
- COCH N/A
- EPS
- EDRY N/A
- COCH N/A
- Revenue
- EDRY $55,867,583.00
- COCH $212,000.00
- Revenue This Year
- EDRY N/A
- COCH $8.04
- Revenue Next Year
- EDRY $28.27
- COCH $15.39
- P/E Ratio
- EDRY N/A
- COCH N/A
- Revenue Growth
- EDRY 10.25
- COCH N/A
- 52 Week Low
- EDRY $7.60
- COCH $1.21
- 52 Week High
- EDRY $24.80
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- EDRY 52.46
- COCH 51.56
- Support Level
- EDRY $8.95
- COCH $1.36
- Resistance Level
- EDRY $9.34
- COCH $1.47
- Average True Range (ATR)
- EDRY 0.53
- COCH 0.10
- MACD
- EDRY 0.06
- COCH 0.00
- Stochastic Oscillator
- EDRY 28.60
- COCH 47.45
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.